Date of this Version
9-1-2016
Document Type
Article
Abstract
This viewpoint is a global call to promote fundamental and applied research aiming toward designing smart nanocarriers of desired properties, novel noninvasive strategies to open the blood–brain barrier (BBB), delivery/release of single/multiple therapeutic agents across the BBB to eradicate neurohuman immunodeficiency virus (HIV), strategies for on-demand site-specific release of antiretroviral therapy, developing novel nanoformulations capable to recognize and eradicate latently infected HIV reservoirs, and developing novel smart analytical diagnostic tools to detect and monitor HIV infection. Thus, investigation of novel nanoformulations, methodologies for site-specific delivery/release, analytical methods, and diagnostic tools would be of high significance to eradicate and monitor neuroacquired immu-nodeficiency syndrome. Overall, these developments will certainly help to develop personalized nanomedicines to cure HIV and to develop smart HIV-monitoring analytical systems for disease management.
Identifier
FIDC001415
Recommended Citation
Kaushik, Ajeet; Jayant, Rahul Dev; and Nair, Madhavan, "Advancements in nano-enabled therapeutics for neuroHIV management" (2016). HWCOM Faculty Publications. 103.
https://digitalcommons.fiu.edu/com_facpub/103
Creative Commons License
This work is licensed under a Creative Commons Attribution-Noncommercial 3.0 License
Rights Statement
In Copyright. URI: http://rightsstatements.org/vocab/InC/1.0/
This Item is protected by copyright and/or related rights. You are free to use this Item in any way that is permitted by the copyright and related rights legislation that applies to your use. For other uses you need to obtain permission from the rights-holder(s).
Comments
Originally published in the International Journal of Nanomedicine.